[1]GIANNINI C, BRCHOT C.Hepatitis C virus biology[J].Cell Death Differ, 2003, 10 (Suppl 1) :s27-s38.[2]XIE R, ZHAO H, OU WN, et al.The difference in distribution of HCV genotypes between patients infected with HCV by transfusion and non-transfusion routes[J].Chin J Exp Clin Virol, 2004, 18 (3) :247-250. (in Chinese) 谢尧, 赵辉, 鸥蔚妮, 等.不同感染途径慢性丙型肝炎患者HCV基因型分布的差异[J].中华实验和临床病毒学杂志, 2004, 18 (3) :247-250.[3]HUANG XJ, LYU X.Research advanced in hepatitic C vaccine[J].Int J Virol, 2011, 18 (1) :29-32. (in Chinese) 黄小军, 吕欣.丙型肝炎疫苗研究进展[J].国际病毒学杂志, 2011, 18 (1) :29-32.[4]Chinese Society of Infectious Disease and Parasitology and Chinese Society of Hepatology of Chinese Medical Association.Guidelines for the prevention and treatment of hepatitis C[J].J Clin Hepatol, 2004, 20 (4) :197-203. (in Chinese) 中华医学会肝病学分会、传染病与寄生虫病学分会.丙型肝炎防治指南[J].临床肝胆病杂志, 2004, 20 (4) :197-203.[5]SIMMONDS P.Genetic diversity and evolution of hepatitis C virus-15years on[J].J Gen Virol, 2004, 85 (11) :3173-3188.[6]CANDOTTI D, TEMPLE J, SARKODIE F, et al.Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana[J].J Virol, 2003, 77 (14) :7914-7923.[7]SIEVERT W, ALTRAIF I, RAZAVI HA, et al.A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt[J].Liver Int, 2011, 31 (Suppl 2) :61-80.[8]LIAO Q, XU R, WANG M, et al.The correlation of HCV genotypes and viral loads among volunter blood donors in Guangzhou[J].Chin J Immunol, 2012, 28 (3) :242-245. (in Chinese) 廖峭, 许茹, 王敏, 等.广州无偿献血人群中丙型肝炎抗体阳性者HCV基因型与病毒载量的关系[J].中国免疫学杂志, 2012, 28 (3) :242-245.[9]XIE Y, XIE C.Research progress of hepatitisc virus genotyping[J].J Dalian Med Univ, 2010, 32 (4) :416-417. (in Chinese) 解莹, 谢晨, 丙型肝炎病毒基因型分型的研究进展[J].大连医科大学学报, 2010, 32 (4) :416-417.[10]DIAS PT, HAHN JA, DELWART E, et al.Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California[J].BMC Infect Dis, 2011, 29 (11) :208-209.[11]PAN J, YU H, DING Q, et al.Genotypes of hepatitis C virus in patients with chronic hepatitis C[J].J Clin Hepatol, 2012, 15 (5) :390-391. (in Chinese) 潘剑, 俞海英, 丁巧云, 等.慢性丙型肝炎患者HCV基因型分析[J].实用肝脏病杂志, 2005 (19) :75-76.[12]LI WQ, YUAN ZH, XU GH, et al.Progress in hepatitis C genotyping and its clinical significanc[J].World Chin J Digest, 2009, 17 (6) :589-593. (in Chinese) 李伟琴, 袁致海, 徐光华, 等.丙型肝炎基因分型进展及其临床意义[J].世界华人消化杂志, 2009, 17 (6) :589-593.[13]TOYODA H, KUMADA T, SHIMADA N, et al.Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin[J].BMC Infect Dis, 2012, 27 (12) :324-332.[14]BLATT LM, MUTCHNICK MG, TONG MJ, et al.Assessment of hepatitis C vius RNA and genotype from 6807 patients with chronic hepatitis C in the United States[J].J Viral Hepat, 2000, 7 (3) :196-202.[15]SILVESTRI F, PIPAN C, BARILLARI G, et al.Prevalence of hepatitis C virus infection in patients with lymphoproliferative disotders[J].Blood, 1996, 87 (10) :296-301.[16]NIE HM, CHEN JJ, DONG HL, et al.Analysis of clinical characteristics of the infection of HCV genotype 1 and non-genotype1 in china[J].J Clin Hepatol, 2012, 28 (6) :439-442. (in Chinese) 聂红明, 陈建杰, 董慧琳, 等.我国丙型肝炎病毒基因1型与非基因1型的临床特征分析[J].临床肝胆病杂志, 2012, 28 (6) :439-442.
|